Nolato
OM:NOLA B Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
WA
Consensus Narrative from 4 Analysts
Focus On In-Vitro Diagnostics Will Strengthen Future Prospects In Medical Solutions
Key Takeaways Nolato's transformation and innovation in Engineered Solutions enhance profit margins and could boost revenue through favorable product mixes. Strategic focus in Medical Solutions on high-demand areas supports revenue growth with strong cash flow enabling acquisitions and investments.
View narrativeSEK 64.75
FV
3.9% undervalued intrinsic discount6.42%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
New narrative